// App-Quantinova.ai

PB0411 : Hydroxychloroquine as an adjunct treatment for patients with triple positive thrombotic antiphospholipid syndrome- a single centre experience

Researchers

Presenter

  • C. Crossette-Thambiah

Principal Investigators

  • M. Laffan

  • D. Arachchillage

Medical Centers

  • NCRI and Imperial College London, London, United Kingdom

  • Centre for Haematology, Imperial Collegel, London, United Kingdom

  • Department of Immunology and Inflammation, Imperial College London, London, England, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Warfarin

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved